Key result
This is a protocol for a Cochrane Review comparing oral therapeutic options for extended thromboprophylaxis in adults with unprovoked VTE, and contains no results.
Why the study?
Do available oral therapeutic options (aspirin, warfarin, NOACs) prevent VTE recurrence safely in adult patients with a first unprovoked VTE after initial anticoagulation?
Systematic Review
Do available oral therapeutic options (aspirin, warfarin, NOACs) prevent VTE recurrence safely in adult patients with a first unprovoked VTE after initial anticoagulation?
Answers are grounded in this paper and cite their sources.
This is a protocol for a Cochrane Review to evaluate oral therapeutic options for extended thromboprophylaxis in patients with unprovoked VTE.
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To compare the efficacy and safety of the available oral therapeutic options (aspirin, warfarin, new oral anticoagulants (NOACs)) for extended thromboprophylaxis in adult patients with a first unprovoked VTE in order to prevent VTE recurrence after completion of an acceptable initial anticoagulant treatment period as defined in the individual studies.
No takes yet. Share an insight, caveat, or question.
Blickstein et al. (2014) conducted a systematic review in Unprovoked venous thromboembolism. Oral therapeutic options (aspirin, warfarin, new oral anticoagulants) was evaluated on VTE recurrence. This is a protocol for a Cochrane Review comparing oral therapeutic options for extended thromboprophylaxis in adults with unprovoked VTE, and contains no results.
Synapse has enriched 10 related papers. Consider them for comparative context: